Skip to main content

Advertisement

SpringerLink
Log in

Antiphospholipid antibodies in HIV-positive patients

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Antiphospholipid (aPL) antibodies classically have been associated with thrombotic phenomena and abortion in patients with autoimmune diseases. The objective of the present work was to evaluate the frequency of such antibodies in patients infected with HIV and study its association with the presence of clinical manifestations of antiphospholipid syndrome (APS). Using a transversal study, a population of patients diagnosed with HIV, identified through an enzyme-linked immunosorbent assay (ELISA) test and confirmed by Western blotting, aged above 17 years old, was investigated. Through a standard questionnaire, the presence of APS manifestations was investigated, as well as the frequency of rheumatic manifestations. Antibodies against β2 glycoprotein I (anti-β2 GPI) and anticardiolipin (aCL) IgA, IgG, and IgM were investigated by the ELISA method using commercial kits (QUANTA Lite, INOVA Diagnostics). Ninety patients were studied, 47 (52.2%) male and 43 (47.8%) female. Clinical manifestations of APS were detected in 12 patients (13.3%) of the studied population, whereas arthralgia was the most common rheumatic manifestation (38.9%). Of the 90 patients, 40 (44.4%) were reactive for at least one type of aPL antibody (aCL and/or anti-β2 GPI). The frequency of aCL was 17.8%, from which 15 (16.7%) had aCL IgG, 3 (3.3%) IgM, and 1 (1.1%) IgA. The frequency of the anti-β2 GPI antibody was 33.3%, from which 29 (32.2%) were positive for isotype IgA, 4 (4.4%) isotype IgM, and 1 (1.1%) isotype IgG. No association was observed between immunoreactivity for aPL antibodies in general or each isotype in particular and the presence of APS manifestation. In the present study, it was possible to observe a relatively high frequency of aPL antibodies, particularly for isotype IgA anti-β2 GPI in HIV. However, there was no association to APS manifestations, suggesting that such antibodies had no etiopathogenic role in these complications in patients with such retroviral infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311

    Article  PubMed  CAS  Google Scholar 

  2. Santiago M, Martinelli R, Reis MG et al (2004) Diagnostic performance of anti-beta2 glycoprotein I and anticardiolipin assays for clinical manifestations of the antiphospholipid syndrome. Clin Rheumatol 23:485–489

    Article  PubMed  Google Scholar 

  3. Santiago M, Martinelli R, Ko A et al (2001) Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar. Clin Exp Rheumatol 19:425–430

    PubMed  CAS  Google Scholar 

  4. Gratacos E, Torres PJ, Vidal J et al (1995) Prevalence and clinical significance of anticardiolipin antibodies in pregnancies complicated by parvovirus B19 infection. Prenat Diagn 15:1109–1113

    Article  PubMed  CAS  Google Scholar 

  5. Loizou S, Cazabon JK, Walport MJ et al (1997) Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 40:103–108

    Article  PubMed  CAS  Google Scholar 

  6. Biron C, Andreani H, Blanc P et al (1998) Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury. J Lab Clin Med 131:243–250

    Article  PubMed  CAS  Google Scholar 

  7. Cacoub P, Renou C, Rosenthal E et al (2000) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore) 79:47–56

    Article  CAS  Google Scholar 

  8. Harada M, Fujisawa Y, Sakisaka S et al (2000) High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 35:272–277

    Article  PubMed  CAS  Google Scholar 

  9. Yuste JR, Prieto J (2003) Anticardiolipin antibodies in chronic viral hepatitis. Do they have clinical consequences? Eur J Gastroenterol Hepatol 15:717–719

    Article  PubMed  CAS  Google Scholar 

  10. Barton EN, Morgan OS, Smikle MF et al (1993) Reactive serological tests for syphilis in tropical spastic paraparesis: a dilemma. J Trop Med Hyg 96:172–174

    PubMed  CAS  Google Scholar 

  11. Wilson WA, Morgan Ost C, Barton EN et al (1995) IgA antiphospholipid antibodies in HTLV-1-associated tropical spastic paraparesis. Lupus 4:138–141

    PubMed  CAS  Google Scholar 

  12. Faghiri Z, Wilson WA, Taheri F et al (1999) Antibodies to cardiolipin and beta2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis. Lupus 8:210–214

    Article  PubMed  CAS  Google Scholar 

  13. Stimmler MM, Quismorio FP Jr et al (1989) Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 149:1833–1835

    Article  PubMed  CAS  Google Scholar 

  14. Coll Daroca J, Gutierrez-Cebollada J, Yazbeck H et al (1992) Anticardiolipin antibodies and acquired immunodeficiency syndrome: prognostic marker or association with HIV infection? Infection 20:140–142

    Article  PubMed  CAS  Google Scholar 

  15. Carreno L, Monteagudo I, Lopez-Longo FJ et al (1994) Anticardiolipin antibodies in pediatric patients with human immunodeficiency virus. J Rheumatol 21:1344–1346

    PubMed  CAS  Google Scholar 

  16. Falco M, Sorrenti A, Priori R et al (1993) Anti-cardiolipin antibodies in HIV infection are true antiphospholipids not associated with antiphospholipid syndrome. Ann Ital Med Interna 8:171–174

    CAS  Google Scholar 

  17. Palomo I, Alarcon M, Sepulveda C et al (2003) Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients. J Clin Lab Anal 17:209–215

    Article  PubMed  CAS  Google Scholar 

  18. Petrovas C, Vlachoyiannopoulos PG, Kordossis T et al (1999) Antiphospholipid antibodies in HIV infection and SLE with or without antiphospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimmun 13:347–355

    Article  PubMed  CAS  Google Scholar 

  19. Shahnaz S, Parikh G, Opran A (2004) Antiphospholipid antibody syndrome manifesting as a deep venous thrombosis and pulmonary embolism in a patient with HIV. Am J Med Sci 327:231–232

    Article  PubMed  Google Scholar 

  20. Shah I, Chudgar P (2006) Antiphospholipid syndrome in a human immunodeficiency virus 1-infected child. Pediatr Infect Dis J 25:185–186

    Article  PubMed  Google Scholar 

  21. Hassoun A, Al-Kadhimi Z, Cervia J (2004) HIV infection and antiphospholipid antibody: literature review and link to the antiphospholipid syndrome. AIDS Patient Care STDS 18:333–340

    Article  PubMed  Google Scholar 

  22. Leder AN, Flansbaum B, Zandman-Goddard G et al (2001) Antiphospholipid syndrome induced by HIV. Lupus 10:370–374

    Article  PubMed  CAS  Google Scholar 

  23. Santiago MB, Rocha MC, Souza S et al (2000) Anticorpos anti-b2 Glicoproteína I em pacientes com lúpus eritematoso sistêmico. Revista Brasileira de Reumatologia 40:285–290

    Google Scholar 

  24. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Article  PubMed  CAS  Google Scholar 

  25. Taillan B, Roul C, Fuzibet JG et al (1989) Circulating anticoagulants in immunodeficiency virus infection. Results of a prospective study of 157 seropositive patients. Ann Med Interne (Paris) 140:405–407

    CAS  Google Scholar 

  26. Von Landenberg P, Lehmann HW, Knoll A et al (2003) Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 48:1939–1947

    Article  CAS  Google Scholar 

  27. Dalekos GN, Kistis KG, Boumba DS et al (2000) Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to Antiphospholipid syndrome. Eur J Gastroenterol Hepatol 12:67–74

    Article  PubMed  CAS  Google Scholar 

  28. Constans J, Guerin V, Couchouron A et al (1998) Autoantibodies directed against phospholipids or human beta 2-glycoprotein I in HIV-seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies. Eur J Clin Invest 28:115–122

    Article  PubMed  CAS  Google Scholar 

  29. Santiago MB, Cossermelli W, Tuma MF et al (1989) Anticardiolipin antibodies in patients with infectious diseases. Clin Rheumatol 8:23–28

    Article  PubMed  CAS  Google Scholar 

  30. Santiago MB, Stellin R, Gaburo Junior N et al (1990) Antiphospholipid antibodies in syphilis. Braz J Med Biol Res 23:397–402

    PubMed  CAS  Google Scholar 

  31. Gorczyca I, Stanek M, Podlasin B et al (2005) Recurrent cerebral infarcts as the first manifestation of infection with the HIV virus. Folia Neuropathol 43:45–49

    PubMed  Google Scholar 

  32. Santos JL, Cruz I, Martin Herrero F et al (2004) Recurrent coronary thrombosis, factor V Leiden, primary antiphospholipid syndrome and HIV. Rev Esp Cardiol 57:997–999

    Article  PubMed  Google Scholar 

  33. Nunez Sanchez A, Gavela E (2004) Renal failure in an HIV patient. Nefrologia 24(Suppl 3):97–100

    PubMed  Google Scholar 

  34. Loizou S, Singh S, Wypkema E et al (2003) Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis 62:1106–1111

    Article  PubMed  CAS  Google Scholar 

  35. Shen YM, Frenkel EP (2004) Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost 10:277–280

    Article  PubMed  Google Scholar 

  36. Ramos-Casals M, Cervera R, Lagrutta M et al (2004) Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 38:1009–1016

    Article  PubMed  Google Scholar 

  37. Malta JB, Milanelo D, Carvalheiro FA et al (2002) Reiter’s syndrome associated with the acquired immunodeficiency syndrome: a case report. Braz J Infect Dis 6:40–44

    Article  PubMed  CAS  Google Scholar 

  38. Njobvu P, McGill P (2000) Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol 27:1699–1702

    PubMed  CAS  Google Scholar 

  39. Panayiotakopoulos GD, Aroni K, Kyriaki D et al (2003) Paucity of Sjogren-like syndrome in a cohort of HIV-1-positive patients in the HAART era. Part II. Rheumatology (Oxford) 42:1164–1167

    Article  CAS  Google Scholar 

  40. Sued O, Miro JM, Alquezar A et al (2006) Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997–2003). Enferm Infecc Microbiol Clin 24:238–244

    Article  PubMed  Google Scholar 

  41. Kulthanan K, Jiamton S, Omcharoen V et al (2002) Autoimmune and rheumatic manifestations and antinuclear antibody study in HIV-infected Thai patients. Int J Dermatol 41:417–422

    Article  PubMed  Google Scholar 

  42. Cucurull E, Gharavi AE, Diri E et al (1999) IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus. Am J Med Sci 318:55–60

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital Santa Izabel, Salvador, Bahia, Brazil

    Liliana Galrão & Isabella Lima

  2. Service of Infectology, Hospital University Prof. Edgard Santos, Salvador, Bahia, Brazil

    Carlos Brites

  3. Faculty of Medicine of Bahia, Federal University of Bahia, Salvador, Bahia, Brazil

    Carlos Brites

  4. Laboratory of Immunology, Faculty of Pharmacy, Federal University of Bahia, Salvador, Bahia, Brazil

    Maria Luíza Atta & Ajax Atta

  5. Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Bahia, Brazil

    Fernanda Gonzalez & Fernanda Magalhães

  6. Service of Rheumatology, Hospital Santa Izabel, Salvador, Bahia, Brazil

    Mittermayer Santiago

  7. Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Bahia, Brazil

    Mittermayer Santiago

  8. Praça Conselheiro Almeida Couto, 500, Nazaré, Salvador, 40000-000, Bahia, Brazil

    Mittermayer Santiago

Authors
  1. Liliana Galrão
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos Brites
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Luíza Atta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ajax Atta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Isabella Lima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fernanda Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fernanda Magalhães
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mittermayer Santiago
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mittermayer Santiago.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galrão, L., Brites, C., Atta, M.L. et al. Antiphospholipid antibodies in HIV-positive patients. Clin Rheumatol 26, 1825–1830 (2007). https://doi.org/10.1007/s10067-007-0581-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-007-0581-6

Keywords

Search

Navigation